× Silymarin and diabetic nephropathy

× Globally sclerotic glomeruli in IgA nephropathy patients

× Comment on: Association between the proportion of globally sclerotic glomeruli and various morphologic variables and clinical data of IgA nephropathy patients

× Comment on: Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients

× Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients

× Association between the proportion of globally sclerotic glomeruli and various morphologic variables and clinical data of IgA nephropathy patients

× Serum uric acid and diabetic nephropathy

× Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients

× Antiphospholipid syndrome-associated nephropathy: Current concepts

× Ginger and diabetic nephropathy

× IgG deposition in IgA nephropathy patients

× Renoprotective effects of garlic

× Preventive role of erythropoietin against aminoglycoside renal toxicity induced nephropathy; current knowledge and new concepts

× On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view

× Combination of metformin with other antioxidants may increase its renoprotective efficacy

× Renal vascular lesions in IgA nephropathy

× R: IgG deposition in IgA nephropathy patients

× Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience

× Effect of Salvia officinalis on diabetic patients

× Complexity of diabetic nephropathy pathogenesis and design of investigations

× Medicinal plants for renal injury prevention

× Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy

× Metformin and renal injury protection

× AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients

× Significance of hyperuricemia in immunoglobulin A nephropathy

× Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease

× Significance of segmental glomerulosclerosis in IgA nephropathy: What is the evidence?

× C1q nephropathy- unity in diversity

× Pattern of biopsy proven renal diseases at PNS SHIFA, Karachi: A cross-sectional survey

× IgM nephropathy: timely response to a call for action

× Comment on ; Post-infectious glomerulonephritis presenting as acute renal failure in a patient with Lyme disease

× Atypical presentations of the sarcoidosis with kidney involvement

× Assessing of the relationship between renal function tests and retinopathy stage in patients with type II diabetes

× Diabetes and end-stage renal disease; a review article on new concepts

× Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy

× BK virus nephropathy is not always alone

× Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography

× IgA-dominant post-infectious glomerulonephritis; making another case in support of renal biopsy in type 2 diabetic nephropathy

× Tempol effects on diabetic nephropathy in male rats  

× Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy

× Incidence of contrast-induced nephropathy a prospective study

× Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

× Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience

× Updated Oxford classification of IgA nephropathy: expanding scope of the schema 

× Association of CD147 renal expression with morphologic lesions of Oxford classification in IgA nephropathy patients

× Potential adverse effects of amphetamines on kidney; a narrative review on current knowledge

× The therapeutic effect of autologous bone marrow mesenchymal stem cells to prevent the progress of chronic allograft nephropathy

× Impact of oxygen therapy to ameliorate contrast-induced nephropathy in patients with acute coronary syndrome undergoing emergency angiography; a double-blinded clinical trial

× Association between the methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms and the risk of diabetic nephropathy; a meta-analysis

× Apolipoprotein L1 associated nephropathy; an overview 

× Predicting renal outcomes in immunoglobulin A vasculitis nephritis; from ISKDC classification to Oxford MEST-C classification 

× Association between serum insulin like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 levels and chronic kidney disease in diabetic patients

× Urinary neutrophil gelatinase-associated lipocalin in early detection of diabetic nephropathy; a pilot study

× The potential effects of dietary flavones on diabetic nephropathy; a review of mechanisms

× Effect of allopurinol on diabetic nephropathy; a double-blind clinical trial study

× Lack of association between diabetic nephropathy and human leukocyte antigen type 2 (HLA II-DQ1) in patients with type 2 diabetes mellitus in west of Iran

× Ameliorative impact of sodium–glucose cotransporter-2 inhibitors in diabetic kidney disease; a mini- review to current evidence

× Management of a newly diagnosed case of myeloma kidney in a recently COVID-19 recovered patient

× The role of remote ischemic preconditioning in preventing contrast-induced nephropathy following invasive coronary angiography; a randomized controlled trial

× Prevalence of renal pathological disorders in kidney transplant recipients: an observational study in the north of Iran

× Pregnancy in immunoglobulin A nephropathy patients; an updated review

× Adipose derived mesenchymal stem cells and their role in management of kidney diseases